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(continued) their mind or if symptoms worsen.  The best possible alternative therapy must be provided. In 
effect, patients who choose to leave AMA should be offered as much continuing therapy, social support and 
follow up assistance as we would arrange for all other patients. 
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A 33 year old African American male was admitted to the University of Missouri I.M. Service, referred from 
a community hospital for uncontrolled hypertension.  He was initially diagnosed with hypertension approx-
imately ten years ago; the condition had been worsening over the past 2-3 months despite escalating doses 
of antihypertensive agents.  In the office on the day of admission, his blood pressure was 210/110 and he 
was “not feeling good.” 
The patient was transported to the stepdown unit where more information was obtained.  He complained of 
increasing fatigue, occasional headaches with blurred vision and chest pressure, worse in the morning.  He 
reported increasing periorbital puffiness but was unable to specify a time period; he had lost 55 lbs over the 
past 8 months via a diet modification program.  He had been diagnosed with diabetes 3 months ago and 
was controlling his glucose with diet and Metformin.  Daily glucose checks range from the 130s-140s.  He 
also reported that he had been treated for hypokalemia over the past 2 months and was currently taking K-
Dur 60 mEq twice daily. 
His past history was remarkable for essential hypertension, diabetes mellitus, GERD and obesity.  His cur-
rent medications included lisinopril, amlodipine, triamterene/HCTZ, Metformin, K-Dur, metoprolol, ome-
prazole and cyclobenzaprine (as needed).  He had no medical allergies.  The patient reported a 40 pack-year 
history of tobacco use (and was still smoking) but denied excessive use of alcohol.  He works as a machine 
operator and is engaged to be married.  Family history was remarkable for hypertension and diabetes. 
Physical examination revealed a blood pressure of 174/122, T 36.2 C, P 78, R 16 and O2 sat 96% (RA).  Signifi-
cant findings included mild periorbital edema, acanthosis nigricans at the nape of the neck and striae over 
the trunk and antecubital fossae.  There was no JVD, chest was clear to auscultation and no murmur, rubs or 
gallops were noted.  He was fully alert and oriented with clear, fluent speech and no focal neurologic defi-
cits. 
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Rise  Labs revealed Na 140, K 2.5, Cl 97, BUN 12, Cr 1.0, Glucose 190, Ca 8.8 and Alb 3.4.  CBC was normal; UA 
showed trace protein but was otherwise normal.  His EKG revealed NSR with no ischemic ST-T changes and 
his troponin I was 0.02. 
Let’s stop and consider a few points: 
 What factors could be contributing to his poorly controlled hypertension? 
 How should his blood pressure be managed at this point? 
 Should he be evaluated for secondary causes of hypertension or is this just another “routine” case of hypertensive 
urgency? 
 What are your thoughts regarding his weight loss, newly diagnosed diabetes and hypokalmia? 
A CT of the abdomen and pelvis was obtained which showed a “large right adrenal region heterogeneously 
enhancing mass, 7.5 cm x 5.1 cm x 5.2 cm.  Multiple enhancing lesions in the liver, multiple bilateral lung par-
enchymal soft tissue nodules, a small T9 sclerotic focus and minimal pericardial effusion were also noted. 
The astute senior resident then orders: ACTH 2 pg/ml (7-69), plasma rennin 0.4 ng/ml (0.2-1.6), plasma aldos-
terone 112 ng/ml (<31), AM cortisol 31.2 (6.7-22.6), 24-hr urine free cortisol 925 mcg (<85), a low dose dexa-
methasone suppression test 35.7 mcg/dL, a high dose dexamethasone suppression test 38.9 mcg/dL, DHEA 
14.6 ng/ml (1.9-7.6), testosterone 185 (400-1080) and free testosterone 45 (47-244).  24 hr urine metanephrines, 
VMA and catecholamines were normal 
More points to consider: 
 What is your differential diagnosis for this patient? 
 How do the above results change our management of this patient’s hypertension? 
 What are your next steps in the diagnostic workup? 
Once the patient’s blood pressure was stabilized, he was sent home and brought back in four weeks for a 
laparoscopic adrenalectomy and partial hepatectomy with biopsies.  His postoperative course was compli-
cated by hypertensive crisis, respiratory failure and altered mental status.  Pathology confirmed the diagnosis 
of adrenocortical carcinoma and further workup showed metastases in the liver, lung, bone and brain (stage 
IV disease).  After consultation with Hematology-Oncology, the patient opted for hospice care. 
 
Discussion:  This case demonstrates a rare cause for secondary hypertension, adrenocortical carcinoma 
(ACC).  The patient’s presentation raises the possibility of several endocrinologic causes for hypertension, in-
cluding Cushing’s Syndrome and hyperaldosteronism. 
ACC is a rare adrenal malignancy, with a population incidence of 1-2 per million.  There is a bimodal age dis-
tribution, with a peak under 5 years of age and another in the 4th-5th decades of life; median age at diagnosis 
is 44 years.  Hyperfunction of the adrenal is common, with 60-80% demonstrating hormone secretion.  The 
primary differential diagnoses for this adrenal mass are neuroblastoma and pheochromocytoma.  ACC, while 
usually sporadic, has been associated with hereditary cancer syndromes, including MEN 1 (parathyroid, pitui-
tary and pancreatic neuroendocrine tumors and carcinomas), Beckwith-Wiedemann Syndrome (Wilms’ tu-
mor, neuroblastoma, hepatoblastoma, ACC) and Li-Fraumeni Syndrome (breast cancer, soft tissue and bone 
sarcomas, brain tumors, ACC). 
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ACC is largely a silent disease unless hormone secretion leads to an early diagnosis; 70% of cases have metasta-
sized at the time of diagnosis and common sites include liver, lung, bone and peritoneum.  Adult disease tends to 
be more aggressive and has a poorer prognosis than ACC in children.  Treatment includes surgical resection and 
adjuvant therapy (mitotane and possible radiation).  Prognosis is often poor and is related to the completeness of 
surgical resection and the presence of distant metastases.  Several small patient series, published in recent years, 
suggest an improvement in survival over time. 
References: Luton, JP et al., Clinical features of adrenocortical carcinoma, prognostic factors and the effect of 
mitotane therapy, NEJM 1990, 322 (17): 1195-1201 
  Brennan MF, Adrenocortical carcinoma, CA Cancer J Clin 37 (6): 348-65, Nov-Dec 1987 
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Efficacy of Esomeprazole for the Treatment of Poorly Controlled Asthma 
 Mastornade, JG et al., Am Lung Assoc Asthma Clinical Research Centers 
 NEJM, Vol 360, No 15, 1487-1499, April 9, 2009 
 Conclusion: despite a high prevalence of GERD in asthma patients, PPI use does not improve control 
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INTRAABDOMINAL INFECTIONS 
Attached are the evidence-based guidelines for the antibiotic treatment of intraabdominal infections 
from the IDSA. 
Solomkin, JS et al., Guidelines for the selection of anti-infective agents for complicated intraabdominal 
infections, Clin Infect Dis 2003; 37:997-1005 
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